ClinicalTrials.gg
Not yet recruitingNCT07666763AcetalResinUpdated Jun 24, 2026

Influence of Acetal Resin Versus Nylon Elastic Cap on Crestal Bone Loss in Mandibular Implant-Supported Overdenture

An interventional study of Acetal Resin and nylon in Bone Loss and Pocket, Periodontal, sponsored by Future University in Egypt. Not yet recruiting. Open to male participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Future University in Egypt · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
Male
01

Study summary

Objective: To evaluate and compare the effect of two different attachment housing materials-Acetal Resin (Polyoxymethylene) versus conventional Nylon elastic caps-on marginal crestal bone loss around dental implants supporting a mandibular overdenture. It also evaluates peri-implant clinical tissue health by measuring pocket depth and the gingival bleeding index.

Read the detailed description

Study Design \& Timeline: A prospective, double-blind, randomized controlled clinical trial with a 1:1 allocation ratio. Clinical and radiographic outcomes will be evaluated at overdenture insertion (baseline), and at 6 and 12 months post-insertion.ethodology \& Analysis: Pre-operative bone volume will be assessed via Cone Beam CT (CBCT). Crestal bone loss will be measured using the long cone parallel radiographic technique , while pocket depth and gingival bleeding will be measured using a William's graduated probing device. Data will undergo normality testing to determine the use of parametric (Independent t-test, Repeated Measures ANOVA) or non-parametric (Mann-Whitney, Friedman) statistical analyse

02

Conditions studied

  • Bone Loss
  • Pocket, Periodontal
03

In context

Bone Diseases, Metabolic

661 studies on the registry are indexed under Bone Diseases, Metabolic; 93 are open to participants now.

This study's planned enrollment of 22 is below the median of 60 across 509 interventional studies indexed under Bone Diseases, Metabolic.

Browse Bone Diseases, Metabolic studies →

Lead sponsor

Future University in Egypt is the lead sponsor of 104 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Completely edentulous mandible.
  • Sufficient bone height/width in mandibular residual ridges.
  • Angles classification class I.
  • Sufficient inter-arch distance

Exclusion criteria

Exclusion Criteria:

  • TMJ disorders.
  • Diabetic
  • Hypertensive
  • Cancer patients.
  • Smoker
  • Osteoporosis.
  • disease
  • Any disease affecting bone/implant stability.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
22 participants (estimated)

Study arms

  • Experimental
    intervention

    acetal

    Device: Acetal Resin

  • Active comparator
    control

    Nylon Elastic

    Device: nylon

Interventions

  • DeviceAcetal Resin

    overdenture supported by implants

  • Devicenylon

    overdenture supported by implants

06

What researchers measure

Primary outcomes

  1. Change in crestal bone levels

    mm

    Time frame: one year

Secondary outcomes

  1. pocket depth changes

    mm

    Time frame: one year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — 1. Chronological Timeline and FrameworkTrial Duration: The active comparative clinical trial is designed to span a duration of one year. Measurement Intervals: Data collection and patient evaluation are scheduled at three distinct time points: at overdenture insertion (baseline), at 6 months, and at 12 months post-insertion

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07666763
Responsible party
Seif eldin Diaa Ezzat (Postgrad stuident, Future University in Egypt) — Principal investigator
First posted
Jun 24, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Jun 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion